BFM
HAE icon

Boothbay Fund Management’s Haemonetics HAE Stock Holding History

Boothbay Fund Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,895
Closed -$220K – 2405
2026
Q1 		$220K Buy
3,895
+850
+28% +$55.4K ﹤0.01% 1750
2025
Q4 		$244K Sell
3,045
-1,957
-39% -$131K ﹤0.01% 1562
2025
Q3 		$244K Buy
5,002
+2,150
+75% +$133K ﹤0.01% 1560
2025
Q2 		$213K Sell
2,852
-5,811
-67% -$385K ﹤0.01% 1227
2025
Q1 		$551K Buy
+8,663
New +$589K 0.01% 821
2024
Q3 		– Sell
-28,179
Closed -$2.33M – 1740
2024
Q2 		$2.33M Buy
28,179
+12,881
+84% +$1.13M 0.06% 449
2024
Q1 		$1.31M Buy
+15,298
New +$1.2M 0.03% 658
2023
Q2 		– Sell
-2,740
Closed -$227K – 1998
2023
Q1 		$227K Buy
2,740
+152
+6% +$12.3K ﹤0.01% 1671
2022
Q4 		$204K Buy
+2,588
New +$208K ﹤0.01% 1606
2021
Q3 		– Sell
-18,604
Closed -$1.24M – 2017
2021
Q2 		$1.24M Buy
18,604
+16,032
+623% +$1.13M 0.04% 595
2021
Q1 		$286K Buy
+2,572
New +$318K 0.01% 1210

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boothbay Fund Management's HAE Position: Q2 2026 in Review

Boothbay Fund Management sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 3,895 shares — an estimated $220K sold.

Boothbay Fund Management first reported a position in HAE in Q1 2021 and held it in 11 quarters. The position peaked at $2.33M in Q2 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Boothbay Fund Management reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 3,895 Haemonetics shares in Q2 2026, an estimated $220K.
  • Boothbay Fund Management first reported a position in Haemonetics in Q1 2021 and held it in 11 quarters.
  • Boothbay Fund Management's Haemonetics position peaked at $2.33M in Q2 2024.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.